3 ms·
That's from a more powered US trial, not the one in China. The argument is that Giliad basically got "unlucky" with this China one (insignificant number of pat
by usaar333 7y ago
That's from a more powered US trial, not the one in China. The argument is that Giliad basically got "unlucky" with this China one (insignificant number of patients/deaths to nullify hypothesis Remdesivir does work)
- khuey 7y agoThe Chinese trial got aborted early due to lack of patients as I understand it so that's not that surprising. It also means this isn't any sort of "miracle" drug though.
- lbeltrame 7y agoNevertheless, it is a drug that has shown some positive efficacy in a real trial (the NIH one, I mean). IMO this is a significant step forward. I hope other viable treatments emerge from the other trials on drugs set to close by June.